- Home
- ELMD vs ACIU Comparison
ELMD vs ACIU Comparison
Compare ELMD & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- ACIU
- Stock Information
- Founded
- ELMD 1992
- ACIU 2003
- Country
- ELMD United States
- ACIU Switzerland
- Employees
- ELMD N/A
- ACIU N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- ACIU Health Care
- Exchange
- ELMD Nasdaq
- ACIU Nasdaq
- Market Cap
- ELMD 206.5M
- ACIU 213.3M
- IPO Year
- ELMD 2010
- ACIU 2016
- Fundamental
- Price
- ELMD $24.86
- ACIU $2.20
- Analyst Decision
- ELMD Strong Buy
- ACIU Strong Buy
- Analyst Count
- ELMD 2
- ACIU 2
- Target Price
- ELMD $35.50
- ACIU $10.00
- AVG Volume (30 Days)
- ELMD 77.2K
- ACIU 122.4K
- Earning Date
- ELMD 08-26-2025
- ACIU 11-04-2025
- Dividend Yield
- ELMD N/A
- ACIU N/A
- EPS Growth
- ELMD 46.55
- ACIU N/A
- EPS
- ELMD 0.85
- ACIU N/A
- Revenue
- ELMD $64,000,000.00
- ACIU $36,362,036.00
- Revenue This Year
- ELMD $11.25
- ACIU N/A
- Revenue Next Year
- ELMD $8.82
- ACIU $1,022.98
- P/E Ratio
- ELMD $29.02
- ACIU N/A
- Revenue Growth
- ELMD 16.97
- ACIU 86.71
- 52 Week Low
- ELMD $16.58
- ACIU $1.43
- 52 Week High
- ELMD $35.56
- ACIU $3.98
- Technical
- Relative Strength Index (RSI)
- ELMD 70.37
- ACIU 52.64
- Support Level
- ELMD $23.61
- ACIU $2.12
- Resistance Level
- ELMD $25.15
- ACIU $2.35
- Average True Range (ATR)
- ELMD 1.00
- ACIU 0.13
- MACD
- ELMD 0.40
- ACIU 0.01
- Stochastic Oscillator
- ELMD 92.74
- ACIU 53.13
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.